Clinical Trials Browser

Phase 1/2 × Has results × Advanced Solid Tumors × Clear all

NCT06242691 2026-06-05

MK-1200-002

Phase 1/2 Completed

13 enrolled 21 charts

Other solid neoplasm

Advanced Solid Tumors

NCT04393298 2025-05-29

A Study to Assess the Safety, Pharmacokinetics and Anti Tumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors

Phase 1/2 Completed

93 enrolled 28 charts

Other solid neoplasm

Advanced Solid Tumors

NCT05394350 2024-11-08

MK-1088-002

Phase 1/2 Terminated

27 enrolled 19 charts

Other solid neoplasm

Advanced Solid Tumors

NCT03379259 2024-10-26

Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors

Phase 1/2 Terminated

39 enrolled 29 charts

Other solid neoplasm

Advanced Solid Tumors

NCT04068519 2024-10-26

Study Investigating Safety, Tolerability, Pharmacokinetics (PK) and Antitumor Activities of Anti-PD-1 (Programmed Death-1) Monoclonal Antibody

Phase 1/2 Completed

300 enrolled 23 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02880371 2022-06-16

A Study of ARRY-382 in Combination With Pembrolizumab for the Treatment of Patients With Advanced Solid Tumors

Phase 1/2 Terminated

82 enrolled 32 charts

Other solid neoplasm

Advanced Solid Tumors

NCT01433991 2021-06-08

A Study of E7050 in Combination With E7080 in Participants With Advanced Solid Tumors (Dose Escalation) and in Participants With Recurrent Glioblastoma or Unresectable Stage III or Stage IV Melanoma After Prior Systemic Therapy (Expansion Cohort and Phase 2)

Phase 1/2 Terminated

30 enrolled 42 charts

Other solid neoplasm

Advanced Solid Tumors

NCT01693562 2021-05-13

A Phase 1/2 Study to Evaluate MEDI4736

Phase 1/2 Completed

1,022 enrolled 42 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02281409 2021-04-23

Safety, Tolerability, and Immunoregulatory Activity of Mogamulizumab (KW-0761) in Subjects With Advanced and/or Metastatic Solid Tumors

Phase 1/2 Completed

17 enrolled 13 charts

Other solid neoplasm

Advanced Solid Tumors

NCT02253992 2020-10-05

An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma

Phase 1/2 Terminated

232 enrolled 17 charts

LymphoidOther solid neoplasm

Advanced Solid Tumors

NCT01781429 2020-03-20

Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies

Phase 1/2 Completed

136 enrolled 25 charts

Other solid neoplasm

Advanced Solid Tumors

NCT03065023 2019-07-30

MK-4621-001

Phase 1/2 Terminated

15 enrolled 23 charts

Other solid neoplasm

Advanced Solid Tumors

NCT00842335 2013-06-24

A Phase 1/2, Open-Label, Dose-Escalation Study of JI-101, in Patients With Advanced Solid Tumors

Phase 1/2 Completed

18 enrolled 9 charts

Other solid neoplasm

Advanced Solid Tumors